The Russia-developed Sputnik V vaccine against coronavirus has been found to be over 95 percent effective, CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday. ......
Scientists have developed a new low-cost nasal swab test which can accurately diagnose the presence of SARS-CoV-2 virus that causes COVID-19 in just 20 minutes. The findings, published in......
The presence of antibodies indicates previous exposure to the SARS-CoV-2 virus but may not always translate into protection against the disease, say scientists, citing imponderables such as what......
Russia's 'Sputnik V' COVID-19 vaccine, approved in the country last month, produced antibody response in all participants with no serious adverse events in small human trials, according to the......
Russia's Sputnik V vaccine against COVID-19 has shown 91.6 per cent efficacy in the phase 3 trial without any serious side effects, according to an interim analysis of data published in The Lancet......